South Africa to Vaccinate Health Care Workers With J&J COVID-19 Vaccine as Part of ‘Implementation Study’
South Africa will move forward with its phase one vaccination program to inoculate its health care workers with the Johnson & Johnson (J&J) COVID-19 vaccine, though the vaccine has not been granted an emergency authorization usage.
Health Minister Zweli Mkhize said on Feb. 10 that the country could no longer wait to immunize its health care workers as the J&J vaccine has “proven effective” against the highly transmissible B.1.351 variant of the CCP (Chinese Communist Party) virus which causes COVID-19 that was first identified in the country in November 2020.
SAHPRA: Ivermectin clinical trials to start soon SAHPRA CEO, Dr Boitumelo Semete-Makokotlela, said that clinical trials from the universities of the Free State, Stellenbosch and Wits are expected to shed light on the drug s benefits. FILE: A health worker shows a box containing a bottle of Ivermectin, a medicine authorized by the National Institute for Food and Drug Surveillance (INVIMA) to treat patients with mild, asymptomatic or suspicious COVID-19, as part of a study of the Center for Paediatric Infectious Diseases Studies, in Cali, Colombia, on July 21, 2020. Picture: Luis Robayo/ AFP.
46 days ago
CAPE TOWN - The South African Health Products Regulatory Authority (SAHPRA) said that three clinical trials on the efficacy of Ivermectin for COVID-19 treatment in South Africa may start soon.
SAHPRA: We ensured controlled access to Ivermectin to treat COVID-19 Despite this, lobby group AfriForum - joined by a general practitioner on behalf of his patients - approached the North Gauteng High Court to allow its use. FILE: A health worker shows a box containing a bottle of Ivermectin, a medicine authorized by the National Institute for Food and Drug Surveillance (INVIMA) to treat patients with mild, asymptomatic or suspicious COVID-19, as part of a study of the Center for Paediatric Infectious Diseases Studies, in Cali, Colombia, on July 21, 2020. Picture: Luis Robayo/ AFP.
47 days ago
CAPE TOWN - The South African Health Products Regulatory Authority (SAHPRA) on Wednesday said it did not buckle under pressure when allowing the use of Ivermectin to treat COVID-19.
SAHPRA to facilitate controlled use of Ivermectin for COVID-19 patients SAHPRA CEO Dr Boitumelo Semete-Makokotlela said the progamme would be open to all patients, with the healthcare professional being responsible for the application and monitoring of the patient. FILE: A health worker shows a box containing a bottle of Ivermectin, a medicine authorized by the National Institute for Food and Drug Surveillance (INVIMA) to treat patients with mild, asymptomatic or suspicious COVID-19, as part of a study of the Center for Paediatric Infectious Diseases Studies, in Cali, Colombia, on July 21, 2020. Picture: Luis Robayo/ AFP.
55 days ago
CAPE TOWN - The South African Health Products Regulatory Authority (SAHPRA) has announced it will facilitate a controlled, compassionate access programme for the use of Ivermectin.